- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapy in rare cancers—adopting the orphans
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 9, Issue 11, Pages 631-642
Publisher
Springer Nature
Online
2012-09-11
DOI
10.1038/nrclinonc.2012.160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How I treat CML blast crisis
- (2012) R. Hehlmann BLOOD
- Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia
- (2012) L.-J. Zhao et al. BLOOD
- Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia
- (2012) R. Beekman et al. BLOOD
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
- (2012) Xuelin Huang et al. CANCER
- Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
- (2012) L. Gandhi et al. CLINICAL CANCER RESEARCH
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors
- (2012) C. Miranda et al. CLINICAL CANCER RESEARCH
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor
- (2012) Heikki Joensuu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of BRAF V600 mutation in melanoma
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Analysis of Mutations in the BCR-ABL1 Kinase Domain, Using Direct Sequencing
- (2012) Filip Razga et al. Molecular Diagnosis & Therapy
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Brentuximab vedotin
- (2012) Anas Younes et al. NATURE REVIEWS DRUG DISCOVERY
- BRAF Inhibition in Refractory Hairy-Cell Leukemia
- (2012) Sascha Dietrich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
- (2012) Nicholas M. Levinson et al. PLoS One
- Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management
- (2011) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
- (2011) Dian Wang et al. ANNALS OF SURGICAL ONCOLOGY
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
- (2011) P. Fenaux et al. BLOOD
- Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis
- (2011) Philippe A. Cassier et al. CANCER
- Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
- (2011) Matija Snuderl et al. CANCER CELL
- Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
- (2011) Grzegorz Helbig et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Advances in therapies for acute promyelocytic leukemia
- (2011) Tomohiko Kamimura et al. CANCER SCIENCE
- Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
- (2011) Howard A. Burris et al. Clinical Breast Cancer
- Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
- (2011) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
- (2011) Aung Naing et al. CLINICAL CANCER RESEARCH
- Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure
- (2011) A. Megan Cornelison et al. Clinical Lymphoma Myeloma & Leukemia
- Effectiveness of adaptive designs for phase II cancer trials
- (2011) Martha Fors López et al. Contemporary Clinical Trials
- CD30-targeted antibody therapy
- (2011) Anas Younes CURRENT OPINION IN ONCOLOGY
- Molecular Analysis of Thyroid Tumors
- (2011) Feriyl Bhaijee et al. ENDOCRINE PATHOLOGY
- Rare cancers are not so rare: The rare cancer burden in Europe
- (2011) Gemma Gatta et al. EUROPEAN JOURNAL OF CANCER
- Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer
- (2011) Marcello Tiseo et al. Expert Review of Anticancer Therapy
- Brentuximab vedotin for the treatment of CD30+lymphomas
- (2011) Kelley V Foyil et al. Immunotherapy
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Response of Lymphangioleiomyomatosis to a Mammalian Target of Rapamycin Inhibitor (Temsirolimus) –Based Treatment
- (2011) Sarina A. Piha-Paul et al. JOURNAL OF CLINICAL ONCOLOGY
- Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
- (2011) Stacy Moulder et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic ( COL1A1-PDGFB ), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors
- (2011) Beatriz Llombart et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Vemurafenib
- (2011) Keith. T Flaherty et al. NATURE REVIEWS DRUG DISCOVERY
- Crizotinib in Anaplastic Large-Cell Lymphoma
- (2011) Carlo Gambacorti-Passerini et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAFMutations in Hairy-Cell Leukemia
- (2011) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Mosaic Activating Mutation inAKT1Associated with the Proteus Syndrome
- (2011) Marjorie J. Lindhurst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Castleman's Disease: From Basic Mechanisms to Molecular Therapeutics
- (2011) H. E. El-Osta et al. ONCOLOGIST
- Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
- (2011) Vivek Subbiah et al. PLoS One
- R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
- (2011) Helen J. Huang et al. PLoS One
- Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
- (2011) Hari Deshpande et al. OncoTargets and Therapy
- Diabetes and Cancer: Is Diabetes Causally Related to Cancer?
- (2011) Sunghwan Suh et al. Diabetes & Metabolism Journal
- Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia
- (2010) Elisabeth P Nacheva et al. BMC GENOMICS
- A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST
- (2010) Jean-Yves Blay CANCER TREATMENT REVIEWS
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
- (2010) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes
- (2010) Carla Heise et al. Expert Review of Anticancer Therapy
- Dermatofibrosarcoma protuberans-derived fibrosarcoma: Clinical history, biological profile and sensitivity to imatinib
- (2010) Silvia Stacchiotti et al. INTERNATIONAL JOURNAL OF CANCER
- Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research
- (2010) David J. Stewart et al. JOURNAL OF CLINICAL ONCOLOGY
- Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease
- (2010) Frits van Rhee et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)
- (2010) H. El-Osta et al. MOLECULAR CANCER THERAPEUTICS
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
- (2010) Rami S. Komrokji et al. Current Hematologic Malignancy Reports
- Anti-CD30 Antibodies for Hodgkin Lymphoma
- (2010) Kelley V. Foyil et al. Current Hematologic Malignancy Reports
- Castleman Disease
- (2009) Danielle M. P. Cronin et al. ADVANCES IN ANATOMIC PATHOLOGY
- BRAFMutation Status in Gastrointestinal Stromal Tumors
- (2009) Isabelle Hostein et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities
- (2009) Hagop Kantarjian et al. CANCER
- AP24163 Inhibits the Gatekeeper Mutant of BCR-ABL and SuppressesIn vitroResistance
- (2009) Mohammad Azam et al. Chemical Biology & Drug Design
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
- (2009) Neil Sheth et al. LEUKEMIA RESEARCH
- Melanoma troops massed
- (2009) Paul H. Huang et al. NATURE
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maladie de Castleman à expression thoracique
- (2009) T. Dégot et al. Revue de Pneumologie Clinique
- Cluster of Hodgkin’s lymphoma in residents near a non-operational petroleum refinery
- (2009) J Dahlgren et al. TOXICOLOGY AND INDUSTRIAL HEALTH
- Heterogeneity in cancer guidelines: should we eradicate or tolerate?
- (2008) G. Pentheroudakis et al. ANNALS OF ONCOLOGY
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Preceding orbital granulocytic sarcoma in an adult patient with acute myelogenous leukemia with t(8;21): a case study and review of the literature
- (2008) Sang-Guk Lee et al. CANCER GENETICS AND CYTOGENETICS
- Chemoprevention and Treatment of Experimental Cowden's Disease by mTOR Inhibition with Rapamycin
- (2008) C. H. Squarize et al. CANCER RESEARCH
- Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics
- (2008) K. Bink et al. HAEMATOLOGICA
- Anaplastic Large-Cell Lymphoma in Women With Breast Implants
- (2008) Daphne de Jong JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical research for rare disease: Opportunities, challenges, and solutions
- (2008) Robert C. Griggs et al. MOLECULAR GENETICS AND METABOLISM
- Prevalence of zebras in general practice: Data from the Continuous Morbidity Registration Nijmegen
- (2008) Floris A. van de Laar et al. European Journal of General Practice
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started